ALEMBIC
Quarterly Results Analysis [Sep2024]
ALEMBIC Quarterly Results
Consolidated | Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹53 Cr | ₹51 Cr | ₹49 Cr | ₹39 Cr | ₹32 Cr | ₹37 Cr | ₹37 Cr | ₹31 Cr |
Expenses | ₹33 Cr | ₹30 Cr | ₹25 Cr | ₹28 Cr | ₹22 Cr | ₹26 Cr | ₹24 Cr | ₹20 Cr |
Operating Income | ₹20 Cr | ₹20 Cr | ₹24 Cr | ₹12 Cr | ₹10 Cr | ₹11 Cr | ₹13 Cr | ₹10 Cr |
Other Income | ₹66 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹48 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr |
Interest | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹3 Cr | ₹3 Cr | ₹1 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
Profit Before Tax | ₹82 Cr | ₹19 Cr | ₹24 Cr | ₹11 Cr | ₹56 Cr | ₹12 Cr | ₹3 Cr | ₹11 Cr |
Profit After Tax | ₹77 Cr | ₹17 Cr | ₹21 Cr | ₹10 Cr | ₹52 Cr | ₹10 Cr | ₹5 Cr | ₹11 Cr |
EPS | ₹4.71 | ₹2.17 | ₹2.81 | ₹2.39 | ₹3.53 | ₹1.73 | ₹1.88 | ₹1.78 |
Industry Peers & Returns | 1W | 1M | 1Y |
ALEMBIC | -5.5% | 13% | 56.2% |
SUN PHARMACEUTICAL INDUSTRIES | -0.1% | 1.7% | 45.7% |
CIPLA | 1.7% | 0.5% | 23.7% |
DR REDDYS LABORATORIES | 5.7% | 12.4% | 18.5% |
ZYDUS LIFESCIENCES | -1.4% | 3.1% | 44.8% |
DIVIS LABORATORIES | -0.1% | -2.2% | 56.9% |
MANKIND PHARMA | 4.2% | 9.8% | 49.8% |
TORRENT PHARMACEUTICALS | 2.2% | 10.6% | 61.7% |
LUPIN | 4.1% | 5.1% | 71.7% |
ALEMBIC Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 4.19 % |
Y-o-Y | 63.91 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2024 | ₹53 Cr | 4.19 | |
Jun2024 | ₹51 Cr | 3.55 | |
Mar2024 | ₹49 Cr | 24.72 | |
Dec2023 | ₹39 Cr | 21.81 | |
Sep2023 | ₹32 Cr | -12.38 | |
Jun2023 | ₹37 Cr | -0.75 | |
Mar2023 | ₹37 Cr | 21.27 | |
Dec2022 | ₹31 Cr | - |
ALEMBIC Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -4.07 % |
Y-o-Y | 92.81 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2024 | ₹20 Cr | -4.07 | |
Jun2024 | ₹20 Cr | -15.53 | |
Mar2024 | ₹24 Cr | 106.76 | |
Dec2023 | ₹12 Cr | 15.07 | |
Sep2023 | ₹10 Cr | -6.62 | |
Jun2023 | ₹11 Cr | -19.18 | |
Mar2023 | ₹13 Cr | 28.83 | |
Dec2022 | ₹10 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -7.92 % |
Y-o-Y | 17.65 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2024 | 36.99% | -7.92 | |
Jun2024 | 40.17% | -18.44 | |
Mar2024 | 49.25% | 65.82 | |
Dec2023 | 29.7% | -5.53 | |
Sep2023 | 31.44% | 6.54 | |
Jun2023 | 29.51% | -18.55 | |
Mar2023 | 36.23% | 6.22 | |
Dec2022 | 34.11% | - |
ALEMBIC Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 343.80 % |
Y-o-Y | 49.51 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2024 | ₹77 Cr | 343.80 | |
Jun2024 | ₹17 Cr | -18.18 | |
Mar2024 | ₹21 Cr | 114.62 | |
Dec2023 | ₹10 Cr | -80.82 | |
Sep2023 | ₹52 Cr | 419.18 | |
Jun2023 | ₹10 Cr | 111.91 | |
Mar2023 | ₹5 Cr | -56.56 | |
Dec2022 | ₹11 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 326.01 % |
Y-o-Y | -8.78 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2024 | 146.12 % | 326.01 | |
Jun2024 | 34.3 % | -20.99 | |
Mar2024 | 43.41 % | 72.06 | |
Dec2023 | 25.23 % | -84.25 | |
Sep2023 | 160.19 % | 492.42 | |
Jun2023 | 27.04 % | 113.59 | |
Mar2023 | 12.66 % | -64.19 | |
Dec2022 | 35.35 % | - |
ALEMBIC Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 117.05 % |
Y-o-Y | 33.43 % |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2024 | ₹4.71 | 117.05 | |
Jun2024 | ₹2.17 | -22.78 | |
Mar2024 | ₹2.81 | 17.57 | |
Dec2023 | ₹2.39 | -32.29 | |
Sep2023 | ₹3.53 | 104.05 | |
Jun2023 | ₹1.73 | -7.98 | |
Mar2023 | ₹1.88 | 5.62 | |
Dec2022 | ₹1.78 | - |
You may also like the below Video Courses